TLR8 (Toll-like receptor 8) variants and mutations
TLR8 (also known as Toll-like receptor 8) is a human protein-coding gene encoding a toll-like receptor 8 protein. It senses single-stranded RNA degradation products in endosomes of monocytes and other immune cells and promotes inflammatory cytokine production. Gain-of-function variants can cause immunodeficiency with neutropenia and dysregulated B-cell development. This analysis covers 1,253 TLR8 variants and mutations. Of these, 91% have computational variant effect predictions. Disease context includes immunodeficiency 98 with autoinflammation, X-linked, osteoarthritis, and autoimmune hemolytic anemia. Example TLR8 variants include M1?, M1V, and E2K.
Variant analysis overview
- Gene: TLR8
- Protein: Toll-like receptor 8
- UniProt accession: Q9NR97
- Organism: Homo sapiens
- Variants analyzed: 1253
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 892 unspecified-consequence records; 159 missense variants; 182 synonymous variants; 7 stop-gained variants; 12 frameshift variants; 1 substitution
- Prediction scores: 1,146 variants have prediction scores (91% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: immunodeficiency 98 with autoinflammation, X-linked, osteoarthritis, autoimmune hemolytic anemia, Systemic autoinflammation, lupus erythematosus, autoimmune disorder of central nervous system, systemic lupus erythematosus, neoplasm, common wart, primary cutaneous T-cell non-Hodgkin lymphoma, hepatitis B virus infection, cancer.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 2 domains; 21 post-translational modification sites.
- Structural context: 186 variants have structural context.
- PTM context: 28 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable TLR8 variants
Examples include M1?, M1V, E2K, E2E, N3K, N3N, M4I, M4K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV54317
- M1V (p.Met1Val), rs3764880, ClinGen CA10350147, ClinVar RCV003489042, MetaLR 0.00, MetaSVM -0.94, Benign, not specified
- E2K (p.Glu2Lys), cosmic curated COSV10509, MetaLR 0.04, MetaSVM -1.09
- E2E (p.Glu2Glu), rs764639681, gnomAD X-12910394-G-A, CADD 0.27
- N3K (p.Asn3Lys), NCI-TCGA Cosmic COSV5431, cosmic curated COSV54318, MetaLR 0.03, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- N3N (p.Asn3Asn), rs2043012812, gnomAD X-12910409-T-C, CADD 1.92
- M4I (p.Met4Ile), rs1397585074, gnomAD rs1397585074, ClinGen CA412412434, ClinVar RCV003993361, REVEL 0.11, MetaLR 0.06, Uncertain significance, not provided
- M4K (p.Met4Lys), ExAC rs780074989, TOPMed rs780074989, gnomAD rs780074989, REVEL 0.22, MetaLR 0.05
- M4T (p.Met4Thr), gnomAD X-12919051-T-C, REVEL 0.20, MetaLR 0.06
- F5F (p.Phe5Phe), gnomAD X-12919055-C-T, CADD 1.97
- L6I (p.Leu6Ile), cosmic curated COSV99487, MetaLR 0.05, MetaSVM -1.02
- L6F (p.Leu6Phe), gnomAD X-12919056-C-T, REVEL 0.02, MetaLR 0.06
- Q7* (p.Gln7Ter), cosmic curated COSV10509, CADD 23.80
- Q7H (p.Gln7His), Ensembl rs910861464, CADD 16.00, SIFT 0.00
- S8L (p.Ser8Leu), TOPMed rs2043074531, MetaLR 0.03, MetaSVM -1.03
- S8Y (p.Ser8Tyr), rs1569114468, gnomAD X-12910399-C-A, CADD 8.38, SIFT 0.00
- S8* (p.Ser8Ter), gnomAD X-12919063-C-A, CADD 32.00
- S8S (p.Ser8Ser), rs780443862, gnomAD X-12919064-G-A, CADD 0.16
- S9I (p.Ser9Ile), rs1279702765, gnomAD X-12910411-G-T, CADD 6.27, SIFT 0.00
- S9S (p.Ser9Ser), rs1329079207, gnomAD X-12910412-C-T, CADD 3.86
- S9R (p.Ser9Arg), rs1329079207, gnomAD X-12910412-C-G, CADD 13.10, SIFT 0.00
- M10K (p.Met10Lys), Ensembl rs1806401717, MetaLR 0.06, MetaSVM -1.05
- M10V (p.Met10Val), rs5744077, UniProt VAR 024667, 1000Genomes rs5744077, ESP rs5744077, REVEL 0.04, MetaLR 0.00
- L11L (p.Leu11Leu), rs767404610, gnomAD X-12910424-G-A, CADD 3.23
- L11M (p.Leu11Met), gnomAD X-12919071-C-A, REVEL 0.11, MetaLR 0.07
- T12A (p.Thr12Ala), gnomAD X-12910434-A-G, CADD 0.60, SIFT 0.76
- T12P (p.Thr12Pro), gnomAD X-12910434-A-C, CADD 2.10, SIFT 0.28
- T12I (p.Thr12Ile), rs1220454792, gnomAD X-12910435-C-T, CADD 0.21, SIFT 0.19
- T12T (p.Thr12Thr), gnomAD X-12910436-T-C, CADD 2.29
- C13G (p.Cys13Gly), ExAC rs570794757, gnomAD rs570794757, REVEL 0.07, MetaLR 0.05
- C13Y (p.Cys13Tyr), ExAC rs747672778, gnomAD rs747672778, REVEL 0.11, MetaLR 0.04
- C13R (p.Cys13Arg), gnomAD X-12919077-T-C, REVEL 0.14, MetaLR 0.05
- F15I (p.Phe15Ile), cosmic curated COSV99028, REVEL 0.04, MetaLR 0.04
- L17I (p.Leu17Ile), gnomAD X-12919089-C-A, REVEL 0.03, MetaLR 0.07
- L17Q (p.Leu17Gln), gnomAD X-12919090-T-A, REVEL 0.24, MetaLR 0.15
- L17L (p.Leu17Leu), rs1234971861, gnomAD X-12919091-A-G, CADD 0.46
- I18V (p.Ile18Val), rs151096932, ClinGen CA10350169, ClinVar RCV000915949, ClinVar RCV004029391, REVEL 0.03, MetaLR 0.05, Conflicting interpretations, not specified; not provided
- I18L (p.Ile18Leu), gnomAD X-12919092-A-T, REVEL 0.04, MetaLR 0.07
- I18I (p.Ile18Ile), rs2043074925, gnomAD X-12919094-A-C, CADD 4.49
- S19A (p.Ser19Ala), gnomAD rs1324053224, REVEL 0.01, MetaLR 0.05
- S19F (p.Ser19Phe), TOPMed rs2043074994, gnomAD rs2043074994, REVEL 0.04, MetaLR 0.06
- G20C (p.Gly20Cys), cosmic curated COSV99487, ExAC rs777353095, gnomAD rs777353095, REVEL 0.04, MetaLR 0.07
- G20D (p.Gly20Asp), cosmic curated COSV54317, gnomAD rs866448188, REVEL 0.03, MetaLR 0.05
- G20V (p.Gly20Val), gnomAD rs866448188, REVEL 0.03, MetaLR 0.04
- G20S (p.Gly20Ser), gnomAD X-12919098-G-A, REVEL 0.07, MetaLR 0.05
- G20G (p.Gly20Gly), rs935698799, gnomAD X-12919100-T-A, CADD 3.54
- S21F (p.Ser21Phe), cosmic curated COSV54317
- S21S (p.Ser21Ser), rs2043075175, gnomAD X-12919103-C-T, CADD 4.74
- C22Y (p.Cys22Tyr), TOPMed rs2043075227, MetaLR 0.04, MetaSVM -1.00
- E23* (p.Glu23Ter), rs1292941025, gnomAD X-12910431-G-T, CADD 32.00
- E23E (p.Glu23Glu), rs1365329480, gnomAD X-12910433-G-A, CADD 1.01
- L24F (p.Leu24Phe), cosmic curated COSV10608
- L24I (p.Leu24Ile), ESP rs139980479, ExAC rs139980479, TOPMed rs139980479, gnomAD rs139980479, REVEL 0.01, MetaLR 0.05
- L24L (p.Leu24Leu), rs139980479, gnomAD X-12919110-T-C, CADD 2.54
- C25R (p.Cys25Arg), Ensembl rs1602455316, MetaLR 0.04, MetaSVM -1.04
- C25Y (p.Cys25Tyr), rs143939946, ClinGen CA10350172, ClinVar RCV004115806, ESP rs143939946, REVEL 0.02, MetaLR 0.04, Uncertain significance, not specified
- C25C (p.Cys25Cys), rs56194919, gnomAD X-12919115-C-T, CADD 0.40
- A26T (p.Ala26Thr), ExAC rs759189396, TOPMed rs759189396, gnomAD rs759189396, REVEL 0.00, MetaLR 0.04
- A26A (p.Ala26Ala), gnomAD X-12919118-C-G, CADD 0.29
- E27D (p.Glu27Asp), NCI-TCGA Cosmic COSV5431, cosmic curated COSV54317, MetaLR 0.06, MetaSVM -1.06, Variant assessed as somatic; moderate impact.
- E27K (p.Glu27Lys), rs144647258, ClinGen CA10350176, cosmic curated COSV54321, ClinVar RCV003435898, REVEL 0.03, MetaLR 0.04, Conflicting interpretations, not specified; not provided
- E28* (p.Glu28Ter), NCI-TCGA Cosmic COSV9948, cosmic curated COSV99487, Variant assessed as somatic; high impact.
- E28G (p.Glu28Gly), NCI-TCGA TCGA novel, MetaLR 0.05, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- E28K (p.Glu28Lys), TOPMed rs1435069623, gnomAD rs1435069623, REVEL 0.02, MetaLR 0.04
- E28Q (p.Glu28Gln), cosmic curated COSV10957, REVEL 0.01, MetaLR 0.05
- N29I (p.Asn29Ile), TOPMed rs770057078, gnomAD rs770057078, REVEL 0.04, MetaLR 0.04, Uncertain significance, not specified
- N29K (p.Asn29Lys), gnomAD X-12919127-T-G, REVEL 0.01, MetaLR 0.05
- N29N (p.Asn29Asn), gnomAD X-12919127-T-C, CADD 1.37
- F30L (p.Phe30Leu), Ensembl rs2043075686, MetaLR 0.07, MetaSVM -1.05
- S31P (p.Ser31Pro), ExAC rs761947630, TOPMed rs761947630, gnomAD rs761947630, REVEL 0.04, MetaLR 0.02, Uncertain significance, Immunodeficiency 98 with autoinflammation, X-linked
- S33I (p.Ser33Ile), Ensembl rs2147258283, MetaLR 0.11, MetaSVM -0.98
- S33N (p.Ser33Asn), gnomAD X-12919138-G-A, REVEL 0.03, MetaLR 0.07
- Y34H (p.Tyr34His), gnomAD X-12919140-T-C, REVEL 0.12, MetaLR 0.13
- P35H (p.Pro35His), NCI-TCGA Cosmic COSV9948, cosmic curated COSV99486, Variant assessed as somatic; moderate impact.
- P35S (p.Pro35Ser), cosmic curated COSV54320, MetaLR 0.24, MetaSVM -0.57
- P35P (p.Pro35Pro), rs765270552, gnomAD X-12919145-T-C, CADD 5.77
- C36G (p.Cys36Gly), gnomAD X-12919146-T-G, REVEL 0.52, MetaLR 0.30
- D37E (p.Asp37Glu), ExAC rs777910070, TOPMed rs777910070, gnomAD rs777910070, REVEL 0.10, MetaLR 0.12
- D37H (p.Asp37His), gnomAD X-12919149-G-C, REVEL 0.09, MetaLR 0.22
- D37V (p.Asp37Val), gnomAD X-12919150-A-T, REVEL 0.17, MetaLR 0.22
- D37D (p.Asp37Asp), rs777910070, gnomAD X-12919151-T-C, CADD 0.09
- E38D (p.Glu38Asp), gnomAD rs1417335127, REVEL 0.07, MetaLR 0.07
- E38G (p.Glu38Gly), NCI-TCGA Cosmic COSV5431, cosmic curated COSV54318, REVEL 0.06, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- K39N (p.Lys39Asn), gnomAD X-12910391-G-T, CADD 1.46, SIFT 0.00
- K39Q (p.Lys39Gln), gnomAD X-12910428-A-C, CADD 3.03, SIFT 0.47
- K39E (p.Lys39Glu), gnomAD X-12910428-A-G, CADD 5.17, SIFT 0.69
- K39K (p.Lys39Lys), rs958616567, gnomAD X-12910430-G-A, CADD 2.79
- K39R (p.Lys39Arg), rs1301306555, gnomAD X-12910441-A-G, CADD 9.98, SIFT 0.48
- K40E (p.Lys40Glu), gnomAD X-12919158-A-G, REVEL 0.04, MetaLR 0.05
- Q41H (p.Gln41His), ESP rs371285063, ExAC rs371285063, TOPMed rs371285063, gnomAD rs371285063, REVEL 0.01, MetaLR 0.04
- Q41K (p.Gln41Lys), gnomAD rs2043075967, REVEL 0.02, MetaLR 0.04, Uncertain significance, not specified
- D43G (p.Asp43Gly), gnomAD rs1326691885, REVEL 0.09, MetaLR 0.03
- S44L (p.Ser44Leu), TOPMed rs906746657
- S44P (p.Ser44Pro), TOPMed rs1042533074, MetaLR 0.12, MetaSVM -1.04
- S44C (p.Ser44Cys), rs1468707465, gnomAD X-12919170-TCA-T, CADD 13.00
- V45I (p.Val45Ile), ExAC rs766470317, TOPMed rs766470317, gnomAD rs766470317, REVEL 0.02, MetaLR 0.07
- V45V (p.Val45Val), rs751956842, gnomAD X-12919175-T-G, CADD 0.25
- I46V (p.Ile46Val), gnomAD X-12919176-A-G, REVEL 0.02, MetaLR 0.06
- A47S (p.Ala47Ser), gnomAD rs1414173481
- A47V (p.Ala47Val), cosmic curated COSV10725, MetaLR 0.03, MetaSVM -1.02
- E48Q (p.Glu48Gln), 1000Genomes rs191299747, ExAC rs191299747, gnomAD rs191299747, REVEL 0.07, MetaLR 0.09
- S50S (p.Ser50Ser), gnomAD X-12919190-C-T, CADD 5.35
- N51S (p.Asn51Ser), Ensembl rs372006583, REVEL 0.00, MetaLR 0.05
- N51N (p.Asn51Asn), rs1324901780, gnomAD X-12919193-T-C, CADD 1.01
- R52C (p.Arg52Cys), NCI-TCGA Cosmic COSV5431, cosmic curated COSV54317, REVEL 0.16, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- R52H (p.Arg52His), rs781778459, NCI-TCGA Cosmic COSV5431, cosmic curated COSV54317, ExAC rs781778459, REVEL 0.17, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- R52P (p.Arg52Pro), ExAC rs781778459, TOPMed rs781778459, gnomAD rs781778459, MetaLR 0.16, MetaSVM -1.00
- R53* (p.Arg53Ter), cosmic curated COSV54318, gnomAD rs1286007013, CADD 33.00
- R53Q (p.Arg53Gln), TOPMed rs1352055700, gnomAD rs1352055700, REVEL 0.04, MetaLR 0.05
- Q55P (p.Gln55Pro), gnomAD X-12919204-A-C, REVEL 0.09, MetaLR 0.07
- E56K (p.Glu56Lys), NCI-TCGA Cosmic COSV5431, cosmic curated COSV54319, MetaLR 0.13, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- E56* (p.Glu56Ter), gnomAD X-12919206-G-T, CADD 34.00
- V57I (p.Val57Ile), gnomAD rs2043076680, REVEL 0.17, MetaLR 0.11
- V57F (p.Val57Phe), gnomAD X-12919209-G-T, REVEL 0.30, MetaLR 0.17
- V57G (p.Val57Gly), gnomAD X-12919210-T-G, REVEL 0.42, MetaLR 0.21
- V57V (p.Val57Val), rs753247296, gnomAD X-12919211-T-C, CADD 3.98
- P58S (p.Pro58Ser), cosmic curated COSV54321, MetaLR 0.36, MetaSVM -0.23
- P58L (p.Pro58Leu), gnomAD X-12919213-C-T, REVEL 0.57, MetaLR 0.36
- Q59K (p.Gln59Lys), cosmic curated COSV99487, MetaLR 0.05, MetaSVM -1.01, Uncertain significance, not specified
- T60A (p.Thr60Ala), cosmic curated COSV54321, MetaLR 0.08, MetaSVM -1.07
- T60M (p.Thr60Met), 1000Genomes rs57166818, ExAC rs57166818, gnomAD rs57166818, REVEL 0.06, MetaLR 0.07
- T60T (p.Thr60Thr), rs777369333, gnomAD X-12919220-G-A, CADD 1.62
- V61V (p.Val61Val), gnomAD X-12919223-G-A, CADD 7.17
- G62D (p.Gly62Asp), cosmic curated COSV54319, TOPMed rs895108222, REVEL 0.04, MetaLR 0.05, Uncertain significance, not specified
- G62G (p.Gly62Gly), gnomAD X-12919226-C-T, CADD 9.87
- Y64H (p.Tyr64His), gnomAD X-12919230-T-C, REVEL 0.13, MetaLR 0.07
- V65L (p.Val65Leu), gnomAD X-12919233-G-C, REVEL 0.15, MetaLR 0.00
- V65V (p.Val65Val), rs1303781544, gnomAD X-12919235-G-A, CADD 5.06
- T66A (p.Thr66Ala), rs375512332, ClinGen CA10350188, ClinVar RCV004472447, ESP rs375512332, REVEL 0.27, MetaLR 0.25, Uncertain significance, not specified
- T66S (p.Thr66Ser), rs375512332, ClinGen CA326799805, ClinVar RCV004167106, ESP rs375512332, REVEL 0.31, MetaLR 0.29, Uncertain significance, not specified
- T66I (p.Thr66Ile), gnomAD X-12919237-C-T, REVEL 0.50, MetaLR 0.37
- E67K (p.Glu67Lys), cosmic curated COSV54321, MetaLR 0.10, MetaSVM -1.05
- L68P (p.Leu68Pro), cosmic curated COSV54320, REVEL 0.67, MetaLR 0.81
- D69Y (p.Asp69Tyr), ExAC rs770624249, TOPMed rs770624249, gnomAD rs770624249, REVEL 0.26, MetaLR 0.18, Uncertain significance, not specified
- S71P (p.Ser71Pro), Ensembl rs2043077036, REVEL 0.33, MetaLR 0.29
- D72H (p.Asp72His), cosmic curated COSV54317, MetaLR 0.06, MetaSVM -1.00
- D72N (p.Asp72Asn), ExAC rs778375164, gnomAD rs778375164, REVEL 0.07, MetaLR 0.04
- D72G (p.Asp72Gly), gnomAD X-12919255-A-G, REVEL 0.09, MetaLR 0.05
- N73N (p.Asn73Asn), rs1183908488, gnomAD X-12919259-T-C, CADD 5.50
- F74V (p.Phe74Val), NCI-TCGA TCGA novel, REVEL 0.02, MetaLR 0.06, Variant assessed as somatic; moderate impact.
- F74F (p.Phe74Phe), gnomAD X-12919262-C-T, CADD 5.73
- I75I (p.Ile75Ile), gnomAD X-12919265-C-T, CADD 5.80
- H77Q (p.His77Gln), cosmic curated COSV54317, ExAC rs771849849, gnomAD rs771849849, REVEL 0.04, MetaLR 0.07
- H77R (p.His77Arg), rs745722261, NCI-TCGA Cosmic COSV5431, cosmic curated COSV54319, ExAC rs745722261, REVEL 0.08, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- I78K (p.Ile78Lys), cosmic curated COSV54320, MetaLR 0.49, MetaSVM -0.42
- I78V (p.Ile78Val), TOPMed rs1159957082, gnomAD rs1159957082, REVEL 0.02, MetaLR 0.12
- I78T (p.Ile78Thr), gnomAD X-12919273-T-C, REVEL 0.25, MetaLR 0.44
- T79M (p.Thr79Met), cosmic curated COSV10635, 1000Genomes rs201537073, ESP rs201537073, ExAC rs201537073, REVEL 0.18, MetaLR 0.37, Uncertain significance, not specified
- T79T (p.Thr79Thr), rs761665080, gnomAD X-12919277-G-A, CADD 0.82
- N80N (p.Asn80Asn), rs768531771, gnomAD X-12919280-T-C, CADD 2.18
- E81K (p.Glu81Lys), Ensembl rs267606341, MetaLR 0.09, MetaSVM -1.03
- Q84R (p.Gln84Arg), TOPMed rs1463697894, gnomAD rs1463697894, REVEL 0.04, MetaLR 0.08
- Q84* (p.Gln84Ter), gnomAD X-12919290-C-T, CADD 34.00
- G85R (p.Gly85Arg), gnomAD X-12919293-G-A, REVEL 0.07, MetaLR 0.10
- G85E (p.Gly85Glu), gnomAD X-12919294-G-A, REVEL 0.07, MetaLR 0.14
- L86P (p.Leu86Pro), TOPMed rs1379157437, gnomAD rs1379157437, REVEL 0.58, MetaLR 0.64, Uncertain significance, not specified
- Q87* (p.Gln87Ter), NCI-TCGA Cosmic COSV5432, cosmic curated COSV54320, Variant assessed as somatic; high impact.
- Q87Q (p.Gln87Gln), rs749370882, gnomAD X-12919301-A-G, CADD 2.47
- N88T (p.Asn88Thr), gnomAD X-12919303-A-C, REVEL 0.19, MetaLR 0.31
- L89P (p.Leu89Pro), gnomAD X-12919306-T-C, REVEL 0.71, MetaLR 0.74
- T90S (p.Thr90Ser), NCI-TCGA Cosmic COSV5431, cosmic curated COSV54319, MetaLR 0.21, MetaSVM -0.91, Variant assessed as somatic; moderate impact.
- T90P (p.Thr90Pro), gnomAD X-12919308-A-C, REVEL 0.30, MetaLR 0.38
- T90I (p.Thr90Ile), gnomAD X-12919309-C-T, REVEL 0.19, MetaLR 0.23
- K91E (p.Lys91Glu), ExAC rs773370542, gnomAD rs773370542, REVEL 0.14, MetaLR 0.06
- K91I (p.Lys91Ile), gnomAD X-12919312-A-T, REVEL 0.16, MetaLR 0.11
- I92T (p.Ile92Thr), cosmic curated COSV54318, MetaLR 0.39, MetaSVM -0.10
- L94I (p.Leu94Ile), cosmic curated COSV10957, MetaLR 0.52, MetaSVM -0.05
- L94L (p.Leu94Leu), rs1176445876, gnomAD X-12919320-C-T, CADD 7.30
- N95I (p.Asn95Ile), gnomAD rs1308929978, REVEL 0.30, MetaLR 0.26
- N95D (p.Asn95Asp), gnomAD X-12919323-A-G, REVEL 0.37, MetaLR 0.18
- H96Y (p.His96Tyr), ESP rs146700498, ExAC rs146700498, TOPMed rs146700498, gnomAD rs146700498, REVEL 0.10, MetaLR 0.09, Uncertain significance, Immunodeficiency 98 with autoinflammation, X-linked; not specified
- H96R (p.His96Arg), gnomAD X-12919327-A-G, REVEL 0.01, MetaLR 0.09
- N97S (p.Asn97Ser), NCI-TCGA TCGA novel, MetaLR 0.57, MetaSVM 0.29, Variant assessed as somatic; moderate impact.
- N97N (p.Asn97Asn), rs2043077593, gnomAD X-12919331-C-T, CADD 0.67
- P98A (p.Pro98Ala), TOPMed rs2043077626
- P98H (p.Pro98His), NCI-TCGA TCGA novel, MetaLR 0.02, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- N99K (p.Asn99Lys), cosmic curated COSV54320, TOPMed rs994032756, gnomAD rs994032756, REVEL 0.01, MetaLR 0.00
- N99Y (p.Asn99Tyr), cosmic curated COSV99028, MetaLR 0.00, MetaSVM -0.91
- V100A (p.Val100Ala), rs200981848, ClinGen CA10350198, cosmic curated COSV54321, ClinVar RCV004472449, REVEL 0.01, MetaLR 0.00, Uncertain significance, not specified
- V100I (p.Val100Ile), Ensembl rs1035870242, REVEL 0.02, MetaLR 0.00
Public TLR8 analysis runs
- TLR8 analysis run — TLR8 (1,253 variants) — completed 2026-08-19